WATERLOO, Iowa (August 1, 2018)—Leitten Consulting released its latest findings addressing the cost shifts that occur when Medicare delays or fails to provide needed durable medical equipment and supplies to beneficiaries.
sleep apnea
SAN DIEGO and SAN FRANCISCO (July 11, 2018)—ResMed a provider of sleep apnea treatment and connected health solutions, and Verily, an Alphabet company, announced their agreement to form a new joint venture.
New data increases sleep apnea sufferers to nearly 1 billion worldwide.
SAN DIEGO (May 21, 2018)—New data analysis presented by ResMed this week at the American Thoracic Society's 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide—nearly 10 times greater than previous estimates.
Grant to study sleep-disordered breathing for two years; improving patient outcomes.
NEW YORK (April 24, 2018)—The ATS Foundation announced its new ATS Foundation/ResMed Research Fellowship in Sleep-disordered Breathing and PAP Therapy.
The award will provide funding for two years in the amount of $100,000, provided by ResMed, a global provider of connected health with more than 4 million cloud-connected PAP devices monitoring patients every night.
Answers from industry experts
LAS VEGAS (March 27, 2018)—At Medtrade Spring in Las Vegas, Nevada (March 27-29), Royal Philips, a provider of health technology, announced the launch of DreamWear Full face, the third mask option available for its award-winning DreamWear mask system. Philips Respironics used the company’s proprietary design tools to analyze facial data from thousands of 3D scans to create a design that prevents red marks, discomfort, and irritation on the nose bridge.
Undiagnosed sleep apnea is a global health issue.
PORT WASHINGTON, N.Y. (March 13, 2018) Drive DeVilbiss Healthcare will recognize World Sleep Day, March 16, to raise awareness of the need for quality sleep and the prevalence of undiagnosed sleep apnea in Latin America.
The tech giant will co-sponsor a performance of an eight-hour lullaby in Austin, Texas.
AMSTERDAM (March 12, 2018)—Ahead of World Sleep Day on March 16, Royal Philips, a provider in health technology, has released the findings from its annual global survey in the report, “Better Sleep, Better Health. A Global Look at Why We’re Still Falling Short on Sleep,” which looked at what keeps people in 13 countries from getting their optimal night’s rest.
BOSTON (February 8, 2018)—SoClean, the CPAP sanitizing device company based in Oxford, Massachusetts, is adding a new corporate office in Peterborough, NH. Initially, the new Peterborough location will serve as a call center and home base for top marketing and sales executives as they renovate the current space to eventually house additional business functions.
BOSTON (January 9, 2018)—SoClean, the CPAP sanitizing device company based in Oxford, Massachusetts, has successfully partnered with investment firm, DW Healthcare Partners (DWHP), to expand the brand in 2018. The health care-focused private equity investment firm based in Toronto, Canada has deep expertise in scaling mid-size companies to fully realize their global potential.
Self-monitoring for CPAP patients increased adherence, ResMed study finds.
SAN DIEGO (November 21, 2017)—CHEST, the publication of the American College of Chest Physicians, has published a ResMed study that shows patient engagement apps significantly improve adherence to positive airway pressure (PAP) therapy.
The research included more than 128,000 patients, making it the world's largest study to look at sleep apnea and self-monitoring.
ATLANTA (October 19, 2017)—Brightree LLC, a leading provider of cloud-based software to improve business and clinical performance of post-acute care organizations, announced the launch of Brightree ConnectPRO, a powerful resupply management program that combines all of its technology, services and data analytics into one time-saving solution.
Brightree ConnectPRO includes:
CHARLOTTE, N.C. (October 3 2017)—Retailers can increase Q4 foot traffic at their locations with FSA/HSA spenders and Contour Products’ CPAP accessory line. Contour’s full line of CPAP accessory products is now approved for health benefit spending.
Millions of Americans are using these employer accounts to pay for their health needs, and Contour not only wants consumers to be able to use these benefits for comfort, but also make paying for our products easier.
WINTER HAVEN, Fla. (September 13, 2017)—3B Medical announces FDA clearances for two new CPAP masks. The Viva is 3B's newest nasal mask. A light, simple and comfortable design makes this nasal mask stand out from the competition. The Numa Full Face Mask also received FDA clearance and shares the same design philosophy for simplicity, flowing lines and light weight. Both masks provide maximum comfort and superior sealing, to aid patient compliance.
Health insights and alerts available for family members of children and seniors.
WALTHAM, Mass. (August 29, 2017)—EarlySense, known for its contact-free, continuous health monitoring solutions, announced today the EarlySense Live Family Health Monitoring Kit with SmartShare, provides caregivers, such as the parents of young children and adults caring for aging loved ones, with a clinically-proven platform to easily track and manage a dependent's health whether sleeping in a room down the hall or living in another state.
Waterbury, Conn. (August 1, 2017)—Health Complex Medical, one of the leading respiratory care service providers in Connecticut, has launched a new brand position aimed at showcasing its expanded solutions for sleep therapy.
Collaborative sessions with its employees, discussions with physicians and patients and analysis of competitive positioning helped crystalize the branding—which includes a new logo, tagline, collateral system and outreach materials.
AMSTERDAM, (July 19, 2017)—Stemming from the success and positive reception of DreamWear, Royal Philips has introduced a new option to its award-winning line of innovative, open-face sleep therapy masks. The new Gel Pillows module features the same comfort and freedom of movement as the original, but now offers an additional choice in cushion type that can be easily changed out within the same mask frame.
The new PAP device allows sleep apnea patients to get out and live life to the fullest
AMSTERDAM, the Netherlands (April 11, 2017)—Royal Philips announced the launch of DreamStation Go, its newest and smallest positive airway pressure (PAP) device designed to simplify travel for patients living with obstructive sleep apnea (OSA). At half the size of Philips’ previous generation devices, DreamStation Go delivers the same clinically-proven performance and comfort, for reliable, convenient therapy on-the-go.
A new study from ResMed demonstrates the importance of the correct therapy.
MARSEILLES, France and SAN DIEGO (April 6, 2017)—ResMed Inc. today announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA.
New integrations expands the company's ability to manage sleep therapy outcomes
ATLANTA (March 22, 2017)—Brightree a provider of cloud-based software for helping post-acute care companies improve business performance and patient outcomes, today announced that its home medical equipment (HME) billing and business management module has enhanced integration capabilities with AirView and myAir, ResMed’s cloud-based sleep and respiratory care patient management and patient engagement platforms.
The enhanced capabilities include:
The findings are released in celebration of World Sleep Day.
SAN DIEGO (March 17, 2017)—In recognition of World Sleep Day, ResMed, a provider of sleep disorder diagnosis and treatment, has picked its top five sleep apnea research findings of 2016.
Philips aims to deliver optimal ventilation with minimal intervention so patients experience comfortable, restful sleep.
AMSTERDAM, the Netherlands (March 7, 2017)—Royal Philips, today announced the expansion of its Dream Family of products with the new DreamStation Advanced Therapies platform designed to deliver optimal ventilation with minimal mechanical intervention. Through these new offerings, DreamStation now supports the most complex patient cases—those suffering with sleep-disordered breathing and respiratory insufficiencies.